Precision Medicine
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18
A Look at the Billion Dollar Clinical Oncology NGS Market–Part I: Growth Driven by Regional Expansion & Targeted Technologies
2025-03-05
Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases
2025-03-04
Visionary Holdings: Deeply Responding to the Concerns of the Capital Market and Demonstrating Solid Development Strength
2025-02-26
Precision Medicine Market Skyrocketing, Shaking the Industry with $470.53 Billion Expected by 2034
2025-02-10
Key Trends in the Pharmaceutical Pipeline for 2024 — Part I: Transformative R&D Growth Driven by Breakthroughs in Oncology, Neurological, and Metabolic Therapies
2024-10-18
Illumina Stepping It Up in Gene Sequencing Innovation with Global Launch of New Tech—MiSeq i100 Series in Taipei
2024-10-16
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24